Insulet Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones10-14

DJ Insulet Corp. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Insulet Corp. $(PODD)$ shed 1.20% to $138.13 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.02% to 7,805.45 and Dow Jones Industrial Average falling 0.35% to 51,670.10.

The stock's fall snapped a three-day winning streak.

Insulet Corp. closed 61.08% below its 52-week high of $354.88, which the company reached on November 20th.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Eli Lilly & Co. (LLY) fell 1.36% to $1,166.51, DexCom Inc. $(DXCM)$ fell 1.00% to $85.06, and Johnson & Johnson $(JNJ)$ fell 5.73% to $248.61.

Trading volume (1.3 M) remained 432,971 below its 50-day average volume of 1.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled October 13, 2026.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment